Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2015 16:55 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Appointment of Greg Madison to Its Board of Directors

NEW YORK, March 10, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced the appointment of Mr. Greg Madison, the Company's President and Chief...
March 04, 2015 07:45 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Publication of Auryxia(TM) (ferric citrate) Analysis in Journal of the American Society of Nephrology

NEW YORK, March 4, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced the publication of Auryxia™ (ferric citrate) data and expert analyses in...
February 27, 2015 07:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Announces Fourth Quarter and Year-End 2014 Financial Results

NEW YORK, Feb. 27, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal disease...
February 25, 2015 16:10 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences

NEW YORK, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that corporate presentations will be delivered at the following upcoming investor...
February 18, 2015 08:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2014 Financial Results

NEW YORK, Feb. 18, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative therapies to market for patients with renal...
January 21, 2015 19:53 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock

NEW YORK, Jan. 21, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced the pricing of an underwritten public offering of common stock consisting of 9,166,667 shares...
January 20, 2015 16:05 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock

NEW YORK, Jan. 20, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that it has commenced a $100 million underwritten public offering of shares of its common...
January 11, 2015 22:00 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Transition of Leadership

NEW YORK and BOSTON, Jan. 11, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced it will be transitioning the role of Chief Executive Officer from...
January 07, 2015 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) today announced that Ron Bentsur, the Company's Chief Executive Officer, will be presenting at the 33rd Annual...
December 22, 2014 07:30 ET | Source: Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA(TM) (ferric citrate) Tablets in the United States

NEW YORK, Dec. 22, 2014 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") today announced it has begun shipping AURYXIA™ (ferric citrate) tablets to wholesalers in...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right